|
Volumn 23, Issue 5, 2010, Pages 455-
|
Editorial: Progress towards a SARS vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INACTIVATED VIRUS VACCINE;
NONSTRUCTURAL PROTEIN 4;
NONSTRUCTURAL PROTEIN 5;
PROGRAMMED DEATH 1 LIGAND 1;
SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;
SUPPRESSOR OF CYTOKINE SIGNALING 1;
VACCINE;
VIRUS ANTIBODY;
HEPATITIS B VACCINE;
INACTIVATED VACCINE;
VIRUS VACCINE;
ADAPTIVE IMMUNITY;
ARTERIVIRUS;
BACTERIOPHAGE;
CD8+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CORONAVIRUS INFECTION;
CYTOTOXICITY;
DENGUE VIRUS;
DISEASE MODEL;
EDITORIAL;
EQUINE INFECTIOUS ANEMIA VIRUS;
GLYCOSYLATION;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
INNATE IMMUNITY;
LUNG DISEASE;
NATIONAL HEALTH ORGANIZATION;
NATURAL KILLER CELL;
NONHUMAN;
PERSISTENT INFECTION;
SEVERE ACUTE RESPIRATORY SYNDROME;
SIGNAL TRANSDUCTION;
VIRUS NUCLEOCAPSID;
VIRUS REACTIVATION;
VIRUS TRANSMISSION;
ANIMAL;
HAMSTER;
IMMUNOLOGY;
MOUSE;
SARS CORONAVIRUS;
ANIMALS;
CRICETINAE;
DENGUE VIRUS;
HEPACIVIRUS;
HEPATITIS B VACCINES;
HUMANS;
INFECTIOUS ANEMIA VIRUS, EQUINE;
MICE;
PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS;
SARS VIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
VACCINES, INACTIVATED;
VIRAL VACCINES;
|
EID: 77957748262
PISSN: 08828245
EISSN: None
Source Type: Journal
DOI: 10.1089/vim.2010.ed.23.5 Document Type: Editorial |
Times cited : (4)
|
References (0)
|